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Phosphatidylinositol 3-Kinase
Couples the Interleukin-2 Receptor
to the Cell Cycle Regulator E2F
Beadling et al., 1996), and regulation of phosphatidylino-
sitol 3-kinase (PI3K) (Abraham and Wiederrecht, 1996).
It also has been established that IL-2 activates protein
kinase B (PKB), also called Akt, by a PI3K-dependent
pathway (Reif et al., 1997). Moreover, PI3K signals are
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(Roche et al., 1994; Karnitz et al., 1995; Corcoran et al.,³Tumor Biology Center
1996; Mui et al., 1996). However, precisely how theseInstitute for Experimental Cancer Research
signals interact with the cell cycle machinery is un-and Department of Biology
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IL-2 regulates the transit of T cells through the G1/S79106 Freiburg
phase cell cycle checkpoint. IL-2 causes up-regulationGermany
of cyclins D2, D3, and E and down-regulation of the
cyclin-dependent kinase (cdk) p27kip1 inhibitor (Morice
et al., 1993; Turner, 1993; Modiano et al., 1994). ThisSummary
results in increased activity of the cdks and the phos-
phorylation of cdk substrates associated with mamma-Cell cycle progression initiated by interleukin-2 (IL-2)
lian cell cycle progression. However, although biochemi-in T cells is critical for lymphoproliferation and an im-
cal responses induced by IL-2 are known tobe importantmune response. Phosphatidyl inositol 3-kinase (PI3K)
for induction of DNA synthesis, little is known about theis activated by IL-2. However, nuclear targets for PI3K
early signals that regulate cyclins and other moleculesare not known. Here we identify thecell cycle regulator
involved in cell cycle control.E2F as an IL-2 target in T lymphocytes and PI3K as
One of the key events during G1 is the activation ofthe critical signaling pathway. We eliminate both Stat5
the transcription factor E2F (Bartek et al., 1996). Sites
and Raf/MEK pathways from E2F regulation. Protein
for E2F have been identified in genes involved in DNA
kinase B (PKB) is activated by IL-2 via PI3K. The ex-
synthesis, such as dihydrofolate reductase (Slansky and
pression of an active PKB is sufficient to induce E2F
Farnham, 1996), and genes important for cell cycle regu-
activity. Inhibition of PI3K inhibits phosphorylation of lation, such as cyclin E (Botz et al., 1996). For this reason
Rb, induction of cyclin D3, and degradation of p27kip1. the regulation of E2F transcription is an important
These results establish a crucial PI3K/PKB±mediated checkpoint during mitogenesis. Transcriptionally active
link between the IL-2 receptor and the cell cycle ma- E2F is found as a dimer of an E2F family protein, of which
chinery. there are five (E2F1±E2F5), and a dimerizing partner (DP)
protein, of which there are two (DP1 and DP2) (Bartek
Introduction et al., 1996). This dimer is kept transcriptionally silent
and may act as a repressor by binding a pocket protein,
Interleukin-2 (IL-2) controls T cell survival, clonal expan- of which three have been identified: pRb, p107, and
sion, and functional differentiation (Smith, 1988) and in- p130 (Bartek et al., 1996). Cyclin/cdk±mediated phos-
duces the progression of T cells through G1 into the phorylation of pocket proteins results in the release of
S phase of the cell cycle. The IL-2 receptor (IL-2R) is E2F allowing E2F transcriptional activity. E2F transacti-
composed of a, b, and g subunits. IL-2±mediated hetero- vation in response to mitogenicstimulation and the iden-
dimerization of b and g subunits induces protein tyrosine tification of E2F-binding sites in a number of genes criti-
kinase±dependent pathways involving the Src family ty- cal to the regulation of DNA synthesis implicate E2F
rosine kinases Lck and Fyn (Minami et al., 1995; Tani- regulation as a pivotal step in mammalian cell cycle
guchi, 1995) and the Januskinases (JAKs) 1 and 3 (Bead- progression. The absence of E2F1 is associated with
ling et al., 1994; Johnston et al., 1994; Miyazaki et al., defects in the process of apoptosis (Field et al., 1996;
1994; Russell et al., 1994; Witthuhn et al., 1994). Signal- Yamasaki et al., 1996).
ing cascades initiated by the action of IL-2±induced A detailed study of E2F protein complexes in T cells
tyrosine kinases include activation of Ras (Turner et al., (Moberg et al., 1996) demonstrated that all E2F subunits,
1991; Fairhurst et al., 1993; Izquierdo Pastor et al., 1995), including DP1 and DP2, are found in T cells. All three
activation of the transcription factors Stat3 and Stat5 pocket proteins were also detected. The prevailing E2F
(Hou et al., 1995; Johnston et al., 1995; Lin et al., 1995; complexes contained E2F1 or E2F4 complexed to DP1.
Free E2F dimers were found at the G1/S phase bound-
ary. Progress through the G1/S phase boundary is con-§To whom correspondence should be addressed (e-mail: brennan@
icrf.icnet.uk). trolled by IL-2. We therefore explored the possibility
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Figure 1. IL-2 Induces E2ACAT
(A) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with 20 mg of E2ACAT,
divided in two, and seeded in six-well plates.
Cells were stimulated with IL-2 or left unstim-
ulated, harvested at the times indicated, and
assayed for CAT. Results are expressed as a
percentage of the maximum induced by IL-2,
where 100% is 3.9 6 0.2 ng/ml CAT. Similar
results were seen in two other experiments.
(B) Cells were stimulated for 18hr with various
concentrations of IL-2 as indicated, and then
lysed and assayed for CAT activity. CAT ac-
tivity is presented as a percentage of the
maximum induced by 20 ng/ml IL-2, where
100% is 5.7 6 0.3 ng/ml CAT. The data are
from a representative experiment; similar re-
sults were obtained in six more experiments.
(C) Cells were transfected with E2ACAT or
the mutant reporter (E2CAT(E2F2)) and stimu-
lated for 18 hr with 20 ng/ml of IL-2. Cells
were then lysed and assayed for CAT activity,
which is presented as percentage acetyla-
tion. The data are from a representative ex-
periment; similar results were obtained in two
more experiments.
(D) CAT reporters (20 mg), as listed, were co-
transfected with mammalian expression vec-
tors for E2F1 or DP1 alone or together. Cells
were left for 18 hr and then harvested and
lysed, and CAT activity was measured. The
data are from a representative experiment;
similar results were obtained in two more ex-
periments.
that intracellular signals triggered by IL-2 regulate E2F IL-2±deprived Kit225 cells but can be induced by IL-2.
A response is detectable at 8 hr and is sustained at latertranscriptional activity. We show that a signaling path-
way regulated by PI3K is both necessary and sufficient time points. Induction of E2ACAT was dependent on
IL-2, with a maximal response at 20 ng/ml (Figure 1B).to couple the IL-2R to the transcriptional activation of
E2F in T cells. This corresponds to the level of IL-2 required to occupy
the high-affinity IL-2R and overlaps with the dose re-
sponse for the induction of proliferation. An E2CAT con-Results
struct containing the 285 to 140 portion of the E2A
promoter with mutation in the E2F-binding sites (E2CATIL-2 Controls E2F Activity in T Cells
Protein complexes between pocket binding proteins (E2F2)) was tested to investigate the requirement for the
E2F-binding sites. This mutant reporter was not inducedand members of the E2F family of transcription factors
are regulated during T cell activation (Chittenden et al., by IL-2 (Figure 1C). Transcriptionally active E2F consists
of a member of the E2F family in a complex with a1993; Moberg et al., 1996). Proliferating T cells express
free E2Fs composed predominantly of E2F4 and E2F1, DP family member. The data in Figure 1D show that
coexpression of a mammalian expression vector forwhich would be predicted to be transcriptionally active
(Moberg et al., 1996). To monitor E2F transcriptional E2F1 or DP1 alone or for their combination results in
high E2ACAT reporter activity in the absence of IL-2.activity in T cells we used a well-characterized reporter
gene for the transactivation potential of E2F (Ohtani and This confirms the ability of E2ACAT to monitor the tran-
scriptional activity of E2F/DP protein complexes inNevins, 1994; Mann and Jones, 1996), E2ACAT, which
contains two E2F-binding sites upstream of the chlor- Kit225 cells. The mutant reporter, E2CAT(E2F2), was
not induced when cotransfected with the E2F or DP1amphenicol acetyl transferase gene (Murthy et al., 1985).
The T cell leukemia line Kit225 was selected for the expression vectors.
Interactions between hypophosphorylated pRb andpresent study because these cells are dependent on
IL-2 for G1 progression and mitosis but not for cell sur- E2Fs are repressive for E2F transactivation. To explore
whether IL-2 effects on E2ACAT activity can be regu-vival. They arrest in G1 after IL-2 deprivation and remain
IL-2 responsive for cell growth following transient trans- lated by pRb, we examined the consequences of ex-
pressing a construct of pRb (pRbD) that is mutated infection. For these experiments, Kit225 cells were de-
prived of IL-2 for 48 hr. The cells were then transfected its p34cdc2 phosphorylation sites and that acts as a re-
pressor of the transcriptional activity of E2Fs (Hamel etand stimulated with IL-2. Figure 1A shows a time course
of CAT produced from E2ACAT. E2F activity is low in al., 1992). The data in Figure 2A show that IL-2 induction
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between the levels of cyclin/cdk complexes and the
levels of cdk inhibitors such as p16ink and p27kip1 (Sherr,
1996). IL-2 induces down-regulation of cellular levels of
p27kip1 in Kit225 cells (Figure 3A), analogous to the p27kip1
down-regulation induced by IL-2 in peripheral blood
lymphocytes (Nourse et al., 1994). The data in Figure 3B
show that in Kit225 cells transfected with an expression
vector encoding p27kip1, IL-2 is unable to induce E2ACAT
activity, and expression of p27kip1 was confirmed by
Western blot analysis (Figure 3C). These data show that
overexpression of p27kip1 is able to prevent IL-2 induction
of E2F transcriptional activity. The repressive effect of
p27kip1 on IL-2 induction of E2ACAT was selective, as
indicated by the ability of IL-2 to induce Stat5 transcrip-
tional activity in p27kip1±transfected Kit225 cells (Figure
3D). We similarly observed that overexpression of p16ink
selectively suppressed IL-2 induction of E2F activity
(data not shown).
IL-2 Activation of MEK/ERK2 and IL-2 Activation
of Stat5 Transcriptional Activity Are Not
Required for IL-2 Induction of E2F
IL-2 regulates the activity of the p21ras±Raf-1±ERK ki-
nase (MEK)±MAP kinase-2 (ERK2) cascade (Satoh et
al., 1991; Turner et al., 1991; Graves et al., 1992). The
involvement of this pathway in E2F regulation was inves-
tigated with the aid of the inhibitor PD098059. This inhib-
itor prevents MEK activation and selectively blocks acti-
vation of ERK2 (Alessi et al., 1995). To monitor the
effectiveness of the MEK inhibitor in Kit225 cells, we
examined the phosphorylation of ERK2 induced by IL-2
in cells pretreated with PD098059. Hyperphosphory-Figure 2. Effect of a Mutant pRb
lated ERK2 has reduced electrophoretic mobility when(A) Quiesced Kit225 cells (1.5 3 107 per sample) were cotransfected
with E2ACAT reporter with a mammalian expression vector for a analyzed by sodium dodecyl sulfate±polyacrylamide gel
form of pRb in which the cdc2 phosphorylation sitesat been mutated electrophoresis (SDS-PAGE). The data in Figure 4A
(pRbD) or with empty vector as a control. After 4 hr the cells were show that IL-2±regulated hyperphosphorylationof ERK2
stimulated with various doses of IL-2. Eighteen hours later the cells
is inhibited by the MEK inhibitor PD098059, demonstrat-were harvested, lysed, and assayed for CAT. Results are expressed
ing that this inhibitor is effective at blocking the MEK/as a percentage of the maximum E2ACAT induced by IL-2, where
ERK2 pathway in Kit225 cells.100% is 1.79 6 0.2 ng/ml CAT. Similar results were seen in four
experiments. IL-2 activates the transcriptional activity of the ternary
(B) Quiesced Kit225 cells (1.5 3 107 per sample) were cotransfected complex protein Elk-1, which is a well-established target
with various reporters with a mammalian expression vector for pRbD for ERK2 action (Marais et al., 1993; Gille et al., 1995).
or empty vector as a control. After 4 hr the cells were stimulated To monitor Elk-1 transcriptional activity, a fusion protein
with 20 ng/ml of IL-2. Eighteen hours later the cells were harvested,
consisting of the C-terminus of Elk-1 linked to the DNA-lysed, and assayed for CAT activity. Results are expressed as a
binding site of the LexA repressor (Marais et al., 1993)percentage of themaximum induced by IL-2 for each reporter,where
100% is 5.8% 6 1%, 22% 6 2%, and 4.9% 6 1% acetylation for was cotransfected into Kit225 cells with a LexA opera-
E2ACAT, GRRCAT, and AP1CAT, respectively. Similar results were tor-controlled CAT reporter gene. The data in Figure 4B
seen in four experiments. demonstrate that IL-2 can regulate Elk-1 transcriptional
activity in Kit225 cells but that treatment of Kit225 cells
with the PD098059 compound abrogates this response.of E2ACAT activity is suppressed in cells cotransfected
with an expression construct encoding pRbD. Of note, Parallel experiments in which the effects of PD098059
on IL-2 activation of E2F were monitored (Figure 4C)this inhibitory effect of pRbD on the transcriptional activ-
ity of E2Fs was selective. Thus in cells expressing the showed that IL-2 can potently induce E2F activity in the
presence of levels of PD098059 that completely blockpRb mutant, IL-2 was able to induce fully the activity of
AP1CAT (Figure 2B), a reporter gene that monitors the IL-2 activation of Elk-1. These data demonstrate that
activation of the MEK/ERK2 pathway is not essential fortranscriptional activity of IL-2±induced AP1 complexes.
We also assessed the effects of pRbD on the IL-2± IL-2 induction of E2F activity.
IL-2 activation of Stat5 has been suggested to beinduced transcriptional activity of Stat5. The data in Fig-
ure 2B show that IL-2 induction of GRRCAT, a reporter important for IL-2 induction of DNA synthesis (Fried-
mann et al., 1996). To explore the role of Stat5 in IL-2for Stat5 activity, was not suppressed by expression of
pRbD. regulation of E2F activity, we examined the effects of
an inhibitory mutant of Stat5 on IL-2 induction of E2FThe phosphorylation of pRb is mediated by cdks, the
activity of which is determined by a homeostatic balance activity. A truncated form of Stat5, which terminates
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the protein at amino acid 750, Stat5D750, destroys the
transactivation domain of the protein and acts as a pow-
erful inhibitor of Stat5 transcriptional activity (Moriggl et
al., 1996). This silences transcription from Stat5 sites in
cells in which the mutant is expressed. We tested the
effectiveness of Stat5D750 as an inhibitor of IL-2±
induced transcriptional activity of Stat5 in Kit225 cells.
Tyrosine-phosphorylated Stat5 dimers bind with high
affinity to an oligonucleotide consisting of the FcgR1-
GAS (GRR) sequence, and a multimer of this site
linked to the CAT gene acts as a sensitive reporter of
the transcriptional activity of Stat5 dimers (Beadling et
al., 1996). Kit225 cells were transfected with an ex-
pression vector for either wild-type Stat5 or Stat5D750
together with GRRCAT. Figure 4D shows that expres-
sion of Stat5D750 completely abrogated IL-2 induction
of GRRCAT activity, whereas expression of wild-type
Stat5 had no effect. These results verify that Stat5D750
is an effective suppresser of IL-2±induced Stat5 activ-
ity in Kit225 cells. We expressed Stat5D750 in Kit225
cells and examined the consequences for IL-2 induction
of E2Fs. The data in Figure 4E show that expression of
Stat5D750 or the wild-type Stat5 had no effect on the
IL-2 dose response for induction of E2ACAT activity.
The ability of Stat5D750 to suppress IL-2 induction
of GRRCAT completely, with no effect on IL-2 induction
of E2ACAT, indicates that Stat5 transcription is not re-
quired for IL-2 activation of E2Fs.
PI3K Signals Are Necessary and Sufficient
for Induction of E2F Transcriptional
Activity in T Cells
IL-2 activates the classic PI3K that is composed of a
regulatory p85 and a catalytic p110 subunit (Panayotou
and Waterfield, 1992) and that phosphorylates phospha-
tidylinositol (4,5)bisphosphate (PI(4,5)P2), generating phos-
phatidylinositol (3,4,5)trisphosphate (PIP3) and its deriv-
ative, PI(3,4)P2. To test the involvement of PI3K on E2F
regulation in T cells we examined the effect of p85D, an
inhibitory mutant of PI3K, on IL-2 activation of E2F. p85D
is a p85 regulatory subunit that lacks the binding site
for the p110 catalytic subunit and therefore prevents
regulation and recruitment of the active enzyme com-
plex to the plasma membrane (Dhand et al., 1994). Co-
transfection of p85D abrogated IL-2 induction of E2F
Figure 3. Effect of p27 on IL-2 Activation of E2ACAT
almost completely, by 90% (Figure 5A). As a control, we
(A) Quiesced Kit225 cells (5 3 106 per sample) were stimulated assessed the effect of p85D on IL-2 induction of Stat5
with 20 ng/ml IL-2 for the times indicated. Total cell lysates were
transcriptional activity (Figure 5A). Kit225 cells wereseparated by SDS-PAGE, and Western blotting was performed. Pro-
transfected with the GRRCAT reporter, which measurestein was detected using anti-p27kip1 antibodies (PharMingen). Similar
results were seen in seven experiments. the transactivation of Stat5, either with or without the
(B) Quiesced Kit225 cells (1.5 3 107 per sample) were cotransfected p85D expression vector. IL-2±induced CAT activity from
with E2ACAT reporter and various doses of a mammalian expression this reporter was unaffected by expression of the p85
vector for p27kip1 or empty vector as control. After 4 hr the cells were
deletion mutant, demonstrating the selectivity of p85Dstimulated with IL-2 (20 ng/ml). Eighteen hours later the cells were
for IL-2 induction of E2F.harvested, lysed, and assayed for CAT activity. The data shown are
A second strategy to explore the role of PI3K in IL-from a representative experiment; similar results were seen in four
experiments. 2/E2F responses involved the use of the inhibitor
(C) Quiesced Kit225 cells (1.5 3 107 per sample) were transfected LY294002, a well-characterized PI3K inhibitor that binds
with various doses of a mammalian expression vector for p27kip1 as
indicated. Total cell lysates were separated by SDS-PAGE, and
Western blotting was performed. Protein was detected using anti-
p27kip1 antibodies (PharMingen). cells were stimulated with IL-2 (20 ng/ml). Eighteen hours later the
(D) Quiesced Kit225 cells (1.5 3 107 per sample) were cotransfected cells were harvested, lysed, and assayed for CAT activity. The data
with GRRCAT reporter with various doses of a mammalian expres- shown are from a representative experiment; similar results were
sion vector for p27kip1 or empty vector as a control. After 4 hr the seen in four experiments.
Phosphatidylinositol 3-Kinase and E2F
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Figure 4. Effect of PD098059 and Stat5D750
IL-2 Activation on E2ACAT
(A) Quiesced Kit225 cells (5 3 106 per sample)
werepretreated for 1 hr with 25 mM PD098059
and then stimulated with IL-2 (20 ng/ml) for 1
hr. Total cell lysates were separated by SDS-
PAGE, and Western blotting was performed.
Protein was detected using pan-ERK anti-
bodies (Transduction Laboratories). Quiesced
Kit225 cells (1.5 3 107 per sample) were
transfected with (B) 7.5 mg of LexA op.tk CAT
and 15 mg of NlexA Elk-1C expression vector
or (C) 20 mg of E2ACAT. After 3 hr, cells were
treated with 25 mM PD098059 or left un-
treated as controls for 1 hr prior to stimulation
with IL-2 (20 ng/ml) (filled bars) or no stimula-
tion (open bars). Eighteen hours later, cell
were harvested and lysed and CAT activity
was measured. Quiesced Kit225 cells (1.5 3
107 per sample) were transfected with (D) 20
mg of GRRCAT or (E) 20 mg of E2ACAT in the
presence of 15 mg of pXM-Stat5 wild-type,
15 mg of pXM-Stat5D750, or reporter alone,
as a control. After 4 hr cells were stimulated
with various amounts of IL-2. Eighteen hours
later, cells were harvested and lysed and CAT
activity was measured. Representative data
are shown for all parts of this figure; similar
results were seen in three experiments.
to the ATP-binding sites of the p110 catalytic subunit. regulatory domain of PI3K. Membrane targeting of the
p85 regulatory subunit of PI3K does not result in accu-The data in Figure 5B show that IL-2 regulation of E2F
is inhibited in cells pretreated with LY294002. The ef- mulation of cellular D-3 phosphoinositides. Figure 5C
shows that expression of constitutively active rCD2p110fects of LY294002 were dose responsive and selective:
this compound did not prevent IL-2 transcriptional acti- resulted in IL-2±independent E2ACAT activation. E2F
activity was not induced in cells expressing rCD2 alone,vation of Stat5 (Figure 5B). In addition, the PI3K inhibitor
did not significantly down-regulate cellular levels of kinase-inactive rCD2p110KD, or rCD2p85 (Figure 5C).
The failure of rCD2p110KD or rCD2p85 to activate E2A-E2F1 (data not shown). The inhibitory effects of p85D
and LY294002 on IL-2 induction of E2ACAT activity thus CAT shows that the transcriptional activation of E2F
induced by rCD2p110 requires the kinase activity of theindicate that PI3K has a critical role in IL-2 regulation
of E2F transcriptional activity. p110 subunit. rCD2p110 did not induce activity of the
mutant reporter construct E2CAT(E2F2), showing thatTo investigate directly whether PI3K signals are suffi-
cient to induce E2F activity, we examined the effects of the integrity of the E2Fs sites in the promoter is required
for the PI3K response (data not shown).a constitutively active PI3K, rCD2p110 (Reif et al., 1996),
on E2F transcriptional activity in T cells. rCD2p110 is a
chimeric protein of the extracellular and transmembrane
domain of the rat CD2 (rCD2) fused with the p110a cata- Active PI3K Signals Are Not Sufficient
for Cell Cycle Entrylytic subunit of PI3K. This construct targets the enzyme
to the plasma membrane and induces accumulation of The effects of IL-2 and the active PI3K on the transcrip-
tional activity of E2F were comparable. IL-2 inducesPI(3,4)P2 and PIP3 in vivo. As a control, we used an
rCD2p110 molecule with an inactivating point mutation, G1/S phase transition in T cells and we therefore wished
to examine the effect of the constitutively active PI3KR1130 (in the ATP-binding site of p110) that abolishes
its in vivo and in vitro lipid kinase activity. A second on S phase entry. IL-2±deprived quiescent Kit225 cells
were transfected with the constitutivelyactive rCD2p110control was a chimera comprising rCD2 fused to the p85
Immunity
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Figure 5. Effect of PI3K on E2ACAT Re-
sponses in Kit225 Cells
(A) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with 20 mg of E2ACAT
with various amounts of the expression vec-
tor for p85D, as indicated, or 20 mg of
GRRCAT with or without 10 mg of p85D. After
4 hr, cells were stimulated with IL-2 (filled
bars) or left unstimulated (open bars). Eigh-
teen hours later, samples were harvested and
lysed, and CAT activity was measured. Re-
sults are expressed as a percentage of the
maximum CAT induced by IL-2 for both re-
porters, where 100% is 2.3 6 0.2 ng/ml CAT
for E2ACAT and 5 6 0.3 ng/ml CAT for
GRRCAT. Similar results were seen in four
experiments.
(B) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with 20 mg of E2ACAT
and treated with various concentrations of
LY294002 as indicated. After 18 hr samples
were harvested and assayed for CAT activity.
Similar results were seen in four experiments.
(C) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with E2ACAT (20 mg)
with 20 mg of each of rCD2, rCD2p110 (active
PI3K), rCD2p110KD (kinase-dead PI3K), or
rCD2p85 as indicated. Cells were left for 4 hr
prior to stimulation with IL-2 (filled bars) or left
unstimulated (open bars). After 18 hr samples
were harvested and assayed for CAT activity.
Results are expressed as a percentage of IL-
2±induced CAT activity, where 100% is 6.2% 6
0.3% acetylation. Similar results were seen
in seven experiments.
(D) Quiesced Kit225 cells were transfected
with 20 mg of rCD2, rCD2p110 (active PI3K),
and rCD2p110KD (kinase-dead PI3K). After 4
hr, half of the cells were stimulated with IL-2.
After 24 hr cells were labeled with BrdU (20
mg/ml) for 18 hr. Cells were stained with anti-
bodies for rCD2 and BrdU and visualized as
described in Experimental Procedures. One
hundred cells were counted in three separate
experiments. Shown is the percentage of un-
stimulated (open bars) or IL-2±stimulated
(hatched bars) cells in the cell cycle. Data
are the mean and standard error from three
separate experiments.
construct or with the control constructs rCD2, com- cells. However, cells transfected with these constructs
were triggered to incorporate BrdU in response to IL-2.posed of the full-length rCD2, and the kinase-dead
rCD2p110. Cells were stimulated with IL-2 4 hr after These data show that PI3K signals are sufficient to in-
duce the transcriptional activity of E2F but are not suffi-transfection or were left untreated. The cells were cul-
tured for 24 hr, and then bromodioxyuridine (BrdU) was cient to induce DNAsynthesis and G1/S phase transition
in Kit225 cells.added for 18 hr to monitor DNA synthesis. Cells were
stained for rCD2 to detect transfected cells and for BrdU
to estimate the percentage of cells engaged in DNA
synthesis using specific rCD2 and BrdU monoclonal an- The PI3K Effector PKB Regulates E2F
Activity in T Cellstibodies. BrdU incorporation into rCD2-positive cells in
the presence or absence of IL-2 was quantitated by The serine/threonine kinase PKB (Akt) can be activated
by IL-2 via a PI3K-dependent pathway (Reif et al., 1997).fluorescence microscopy. Figure 5D shows the percent-
age of transfected cells that incorporated BrdU. IL-2 Moreover, activation of PI3K signaling pathways by ex-
pression of the membrane-targeted rCD2p110 potentlypotently stimulated the incorporation of BrdU in cells
expressing rCD2. Cells expressing the constitutively stimulates PKB in Kit225 cells (Reif et al., 1997). We
examined whether PKB, as a candidate effector of PI3K,active PI3K, rCD2p110, or the control kinase-dead
rCD2p110KD showed no increase in the percentage of could induce transcriptional activity of E2F in Kit225
cells. gagPKB is a chimeric protein consisting of a viralBrdU-positive cells compared to control IL-2±deprived
Phosphatidylinositol 3-Kinase and E2F
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Figure 6. Effect of Expression of a Constitu-
tively Active gagPKB on E2ACAT Responses
in T Cells
(A) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with E2ACAT (20 mg)
alone or with 20 mg of gagPKB (active PKB)
or PKBKD (kinase dead PKB). Cells were left
for 4 hr prior to stimulation with IL-2 (filled
bars) or no stimulation (open bars). After 18
hr samples were harvested and assayed for
CAT activity. Similar results were seen in
three experiments.
(B) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were transfected with E2ACAT (20 mg)
and various amounts of gagPKB (active PKB)
or PKBKD (kinase-dead PKB). After 22 hr
samples were harvested and lysed and as-
sayed for CAT activity. Similar results were
seen in seven experiments.
(C) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were cotransfected with E2ACAT or the
mutated reporter (E2CAT(E2F2)) and gagPKB
(20 mg) as indicated. After 22 hr samples were
harvested and lysed and CAT activity was
measured. For each of these experiments a
representative experiment is shown; similar
results were seen in three experiments.
(D) Quiesced Kit225 cells (1.5 3 107 per sam-
ple) were cotransfected with E2ACAT with
empty vector, rCD2p110 (20 mg) or gagPKB
(20 mg) as indicated. After 4 hr cells were
treated with 5 mM LY294002 for 20 min prior
to activation with IL-2 (20 ng/ml). Eighteen
hours later samples wereharvested and lysed
and CAT activity was measured. Representa-
tive experiments are shown; similar results
were seen in three other experiments.
Gag protein fused to the N-terminus of PKB. This mole- E2ACAT, whereas gagPKB can rescue E2F transcrip-
cule is myristoylated, is predominantly found at the tional activity in PI3K-inhibited IL-2±activated cells.
plasma membrane, and is constitutively active (Burger- These data position PKB downstream of PI3K in the IL-2
ing and Coffer, 1995). IL-2±deprived Kit225 cells were pathway to E2F.
cotransfected with an expression vector encoding
gagPKB together with E2ACAT. The results (Figures 6A PI3K Regulates Cellular Levels of Cyclin D3,
and 6B) show that coexpression of gagPKB induced p27kip1, and Controls the Phosphorylation
a strong transcriptional activation of E2F. In contrast, of Pocket Proteins Rb and p130
expression of a control, kinase-dead form of PKB con- The use of LY294002 allows biochemical analysis of the
taining an inactivating point mutation in the ATP-binding role of PI3K in IL-2±induced changes in levels of cell
site of the catalytic domain of the kinase did not induce
cycle regulatory proteins and the phosphorylation status
E2ACAT activity. gagPKB induction of E2ACAT was de-
of the pocket proteins pRb and p130. Kit225 cells were
pendent on the integrity of the E2F-binding sites in the
treated with various concentrations of LY294002 priorE2ACAT reporter gene (Figure 6C). These results show
to stimulation with IL-2. Samples were harvested andthat the PKB kinase pathway can generate signals that
protein extracts were generated. The extracts were runsubstitute for IL-2 in the induction of E2F activity.
on SDS-PAGE, and the proteins were Western blottedPKB has been shown to act downstream of PI3K in
and analyzed for various cell cycle proteins (Figure 7).regulating the activity of p70 S6 kinase (Reif et al., 1997).
IL-2 induced up-regulation of cyclin D3 and down-regu-The data in Figure 6D show that expression of gagPKB
lation of p27kip1, and these IL-2 responses were inhibitedcan effectively induce E2F transcriptional activity in the
in cells treated with 5 mM LY294002. These data alsopresence of LY294002, whereas active PI3K or IL-2 can-
show that PI3K signals were required for IL-2±inducednot. PKB activates p70 S6 kinase in a pathway involving
hyperphosphorylation of pRb and p130. We also per-the target for the immunosupressant rapamycin (mTOR;
formed these experiments on peripheral blood±derivedalso called RAFT or FRAP). We found that E2ACAT re-
T lymphoblasts. Figure 7 shows the effects of LY294002sponses induced by IL-2, PI3K, and PKB are only
on IL-2 regulation of cyclin D3, p27kip1, and Rb and p130.partially (40%±50%) inhibited by rapamycin (data not
Inhibition of PI3K inhibited IL-2 down-regulation ofshown). Rapamycin equally modulates IL-2, rCD2p110,
p27kip1 and up-regulation of cyclin D3 and preventedand gagPKB E2F responses. In contrast, LY294002 ef-
fectively abrogates the effect of IL-2 and rCD2p110 on IL-2±induced hyperphosphorylation of pRb and p130.
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Figure 7. LY294002 Inhibits Rb Phosphoryla-
tion, Induction of Cyclin D3, and the Decrease
in p27kip1 in Peripheral Blood Lymphocytes
and Kit225 Cells
Kit225 cells and peripheral blood lympho-
cytes (2 3 106 per ml, 5 ml per sample) were
incubated with IL-2 for 20 hr either alone or
in the presence of the indicated concentra-
tions of LY294002. Total cell lysates were
generated and resolved by SDS-PAGE and
Western blotting was performed. Protein was
detected using specific antibodies for the
proteins indicated. Similar results were seen
in four experiments.
Discussion PI3K induction of E2F activity may involve mTOR-con-
trolled signaling pathways but must involve additional
PI3K/PKB±regulated molecules.Characterization of cytokine regulation of the cell cycle
is important for understanding how these molecules PI3K signals alone are sufficient to induce DNA syn-
thesis in 3T3-L1 adipocytes (Frevert and Kahn, 1997).control lymphocyte proliferative expansion. In the pres-
ent study, we show that the hematopoietic cytokine IL-2 In contrast, although PI3K pathways are sufficient for
E2F activity, they are not sufficient for the induction ofcontrols the transcriptional activity of E2F, and we iden-
tify the signaling pathways used by IL-2 to regulate the DNA synthesis in Kit225 cells. The failure of a single
signaling pathway regulated by PI3K to induce DNAtransactivation potential of E2F. Our results show that
inhibition of ERK or Stat5 had no effect on IL-2 activation synthesis in lymphoid cells also agrees with previous
work on the regulation of T cell proliferation by IL-2.of E2F. Instead, IL-2 activation of E2Fs is a PI3K-depen-
dent response. Moreover, we show that PI3K signals There is thus a general consensus that IL-2±induced
DNA synthesis requires the integration of a network ofare not only necessary but also sufficient to induce E2F
transcriptional activity in Kit225 cells to a level compara- signals generated by the IL-2R b subunit, including sig-
naling pathways involving the proteins Bcl-2 and c-Mycble to that induced by IL-2. PI3K regulates PKB in T
cells (Reif et al., 1997), and the current data establish (Miyazaki et al., 1995; Friedmann et al., 1996; Gaffen et
al., 1996). There is considerable evidence that cytokinethat PKB can substitute for IL-2 or PI3K and induce the
transcriptional activity of E2Fs in Kit225 cells. Therefore activation of STATs is required for the proliferative re-
sponses of lymphoid cells (Kaplan et al., 1996a, 1996b;the present data identify a transcription factor target
for PI3K/PKB signaling pathways and demonstrate that Shimoda et al., 1996; Thierfelder et al., 1996). The pres-
ent results identify a point at which PI3K regulates thePI3K/PKB signals provide a crucial link between hema-
topoietic cytokine receptors and the cell cycle machin- T cell cycle; its positioning relative to other signals will
be the focus of future studies.ery in lymphocytes.
E2F transcriptional activity is regulated by the phos- Finally, it has been recognized for many years that
PI3K is regulated by the hematopoietin family of cyto-phorylation status of Rb and p130. The present results
show that PI3K signals are required for IL-2 induction kines, which are the critical regulators of lymphocyte
clonal expansion. However, no clear function for thisof Rb and p130 hyperphosphorylation in Kit225 cells
and peripheral blood lymphocytes. Rb/p130 phosphory- enzyme in cytokine signaling pathways has been identi-
fied to explain its role in cell cycle control mechanisms.lation is regulated by cyclin D±cdk4/6 complexes. We
show that PI3K signals are required for IL-2 up-regula- The present results identify PI3K and its target effector
PKB as the link from the IL-2 R to E2F. The ability oftion of cyclin D3. E2F transactivation in Kit225 cells is
sensitive to cellular levels of the cyclin/cdk inhibitor PI3K/PKB signals to substitute for cytokines in the in-
duction of E2F identifies a transcription factor target forp27kip1: high levels of p27kip1 result in inhibition of IL-2
activated E2F. PI3K signals are required for IL-2 down- thePI3K/PKB pathway in T cells. The transcription factor
E2F is known to have an important role in the regulationregulation of p27kip1. This indicates that PI3K regulation
of E2F transcriptional activity is regulated by the action of apoptosis and cell cycle progression (Field et al.,
1996; Yamasaki et al., 1996). The importance of PI3Kof this kinase on cellular levels of cyclins and their inhibi-
tors (Figure 8). PI3K signaling pathways previously de- for E2F regulation explains why activation of this lipid
kinase is essential for the proliferative responses ofscribed in T cells include the MEK/ERK2 pathway and
responses controlled by the rapamycin target, mTOR. lymphoid cells.
The present results exclude the ERK2 pathway from any
Experimental Procedurescritical role in IL-2/E2F responses. The PI3K±PKB±
mTOR pathway regulates the activity of p70 S6 kinase
Reagentsbut has other targets, including proteins involved in pro-
The following reagents were used: IL-2 (Chiron); [14C]acetyl coen-
tein translation such as 4E-BP1 (Von Manteuffel et al., zyme A, at 50 mCi/mmol (Amersham); LY294002 (a gift from Zeneca);
1996). Rapamycin causes a partial inhibition of E2F ac- PD098059 (a gift from L. O'Neill, Trinity College, Dublin, Ireland;
antibodies against p27 and Rb (Pharmingen); pan-ERK antibodytivity in IL-2±stimulated cells (data not shown). Thus
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Figure 8. IL-2 Signaling to E2F via PI3K and
PKB
The role of the PI3K signaling pathway to E2F
transactivation in T cells. Our model places
PI3K and PKB upstream of cyclin D3 up-regu-
lationand p27kip1 degradation.This pathway is
required for an increase in cyclin/cdk kinase
activity, leading to Rb phosphorylation and
E2F transactivation.
(Signal Transduction Laboratories); p130 antibodies (Santa Cruz The following expression plasmids have been described: E2F1
(pcDNA3) (Xu et al., 1995); pRbD (pEF) (Hamel et al., 1992); wild-Biotechnology); and cyclin D3 monoclonal antibody (a gift from Gor-
don Peters, Imperial Cancer Research Fund, London, UK). type Stat5 (pXM) and the truncation mutant of Stat5, Stat5D750
(pXM) (Moriggl et al., 1996); gagPKB (pSG5) and kinase-dead Ha-
PKB (pSG5) (Burgering and Coffer, 1995); rCD2 (pEF), rCD2p110Cell Culture
Kit225 cells (Hori et al., 1987), a human IL-2±dependent T cell line, (pEF), rCD2p110KD (pEF), and rCD2p85 (pEF) (Reif et al., 1996); and
p85D (Dhand et al., 1994). The cytomegalovirus-based mammalianwere maintained in RPMI media supplemented with 20 ng/ml IL-2
in a 5% CO2 humidified incubator. In the absence of IL-2 these cells expression vector for DP1 and the mammalian expression vector
for p27 (pcDNA3) were a gift from D. Mann (Imperial Cancer Re-accumulate in the G1 phase of thecell cycle. The cells were deprived
of IL-2 for 48 hr prior to transfection by washing the cells twice in search Fund). Plasmid DNA was purified by CsCl density gradient
centrifugation.RPMI media. For other experiments the cells were deprived of IL-2
for 72 hr. IL-2R±expressing human peripheral blood±derived T
lymphoblasts were generated and maintained as described pre- Transfections and CAT Assay
Kit225 cells were deprived of IL-2 as indicated prior to transfection,viously (Beadling et al., 1994) The cells were quiesced by washing
three times in RPMI and by replacing in RPMI 1640 with 10% serum and 15 3 106 cells were transfected by electroporation with the
amounts of DNA as indicated. Electroporation was carried out within the absence of IL-2 for 48±72 hr.
a Gene Pulser (BioRad) set at 320 V and 960 mFD. After transfection,
cells were replaced in culture in the absence or presence of 20 ng/Plasmids
E2ACAT, originally described by Murthy et al. (1985) and used sub- ml IL-2 for 16±18 hr prior to lysis. Cells were lysed in buffer containing
10 mM Tris (pH 8.0), 1 mM EDTA, 150 mM NaCl, and 0.65% Nonidetsequently by Mann and Jones (1996), comprises 2284bp to 162 of
the E2A promoter upstream of a CAT gene. The transcription activity P-40 (NP-40). Samples were then assayed for CAT activity by radio-
isotope method (Genot et al., 1995) or total CAT present by enzyme-has been mapped to two elements, the first between 229 and 221
and the second between 282 and 266. These have been identified linked immunosorbent assay (CAT ELISA kit, Boehringer Mannheim).
as containing E2F-binding sites, and the E2A promoter has been
used to report on E2F activity (Ohtani and Nevins, 1994; Mann and Western Blotting
Cells (5 3 106 per ml of lysis buffer) were lysed in buffer containingJones, 1996). E2CAT(E2F2) was a generous gift from J. R. Nevins
(Howard Hughes Medical Institute, Duke University Medical Center, 25 mM HEPES (pH 7.4), 75 mM NaCl, 10 mM NaF, 1% NP-40, 1
mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml chymostatin, 1 mMDurham, NC 27710). It contains 285 to 140 from the E2A promoter,
in which both E2F sites have been mutated, upstream of a CAT phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, and 1 mM
Na3VO3. Proteins were concentrated by precipitation with 1.5 vol-gene (Loeken and Brady, 1989). The reporter plasmid GRRCAT con-
tains five copies of the interferon g receptor response element up- umes of acetone. Proteins from 5 3 106 cells were separated by
SDS-PAGE using the following gel conditions: for p27kip1 and cyclinstream of the tk-CAT gene (Beadling et al., 1996). AP1CAT contains
three copies of the sequence for the AP1 site inserted in pBLCAT2 D3, 11% acrylamide/0.3% bis; for MAP kinase, 15% acrylamide/
0.075% bis; and for pRb and p130, 7.5% acrylamide/0.2% bis. Pro-(Williams et al., 1995). LexA OP.tk CAT and the pEF-NLexA Elk-1C
fusion protein have already been described (Marais et al., 1993). teins were transferred to polyvinylidene difluoride membranes and
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detected by Western blot analysis with antibodies as indicated using Dhand, R., Hara, K., Hiles, I., Bax, B., Gout, I., Panayotou, G., Fry,
M.J., Yonezawa, K., Kasuga, M., and Waterfield, M.D. (1994). PIthe enhance chemiluminescence detection system (Amersham).
3-kinase: structural and functional analysis of intersubunit interac-
tions. EMBO J. 13, 511±521.BrdU Analysis of DNA Synthesis in Transfected Cells
Quiesced Kit225 cells (1.5 3 107 cells per sample) were transfected Fairhurst, R.M., Daeipour, M., Amaral, M.C., and Nel, A.E. (1993).
with 20 mg of rCD2 constructs. After 4 hr half of each cell population Activation of mitogen-activated protein kinase/ERK-2 in phytohae-
was stimulated with IL-2. After 24 hr cells were labeled with BrdU magglutin in blasts by recombinant interleukin-2: contrasting fea-
(20 mg/ml) for 18 hr. Cells were harvested, washed, and fixed in 70% tures with CD3 activation. Immunology 79, 112±118.
ethanol for 20 min on ice. Cells were permeabilized with 2 M HCl Field, S.J.,Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Living-
containing 0.1% NP-40 for 30 min at room temperature. The samples ston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions
were blocked for 15 min in phosphate-buffered saline containing in mice to promote apoptosis and suppress proliferation. Cell 85,
3% fetal calf serum and incubated for 10 min with a monoclonal 549±561.
antibody to rCD2 (OX34, 0.9 mg/ml). After two washes, the samples
Frevert, E.U., and Kahn, B.B. (1997). Differential effects of constitu-were incubated in phycoerythrin -conjugated F(ab)92 fragment of
tively active phosphatidylinositol 3-kinase on glucose transport, gly-affinity-isolated rabbit anti-mouse immunoglobulin (Dako) at room
cogen synthase activity and DNA synthesis in 3T3-L1 adipocytes.temperature for 10 min. The samples were washed three times and
Mol. Cell. Biol. 17, 190±198.blocked for 15 min in phosphate-buffered saline containing 3% fetal
Friedmann, M.C., Migone, T.-S., Russell, S.M., and Leonard, W.J.calf serum. The cellswere then incubatedfor 5 min in directly fluores-
(1996). Different interleukin 2 receptor B-chain tyrosines couple tocein isothiocyanate±conjugated anti-BrdU monoclonal antibodies
at least two signaling pathways and synergistically mediate interleu-(Boehringer Mannheim), washed three times, and mounted on
kin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93, 2077±slides. The samples were then visualized using a fluorescence mi-
2082.croscope and counted.
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